Brind.

Hikma Pharmaceuticals is expanding its operations in Ohio, focusing on oral solid dose and nasal inhalation products, supported by state tax credits.

1 report, 1 independent Updated Jun 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Hikma Pharmaceuticals is expanding its operations in Ohio, focusing on oral solid dose and nasal inhalation products, supported by state tax credits.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped